Cargando…
Characterization of human platelet binding of recombinant T cell receptor ligand
BACKGROUND: Recombinant T cell receptor ligands (RTLs) are bio-engineered molecules that may serve as novel therapeutic agents for the treatment of neuroinflammatory conditions such as multiple sclerosis (MS). RTLs contain membrane distal α1 plus β1 domains of class II major histocompatibility compl...
Autores principales: | Itakura, Asako, Aslan, Joseph E, Sinha, Sushmita, White-Adams, Tara C, Patel, Ishan A, Meza-Romero, Roberto, Vandenbark, Arthur A, Burrows, Gregory G, Offner, Halina, McCarty, Owen JT |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992052/ https://www.ncbi.nlm.nih.gov/pubmed/21059245 http://dx.doi.org/10.1186/1742-2094-7-75 |
Ejemplares similares
-
RTL551 Treatment of EAE Reduces CD226 and T-bet+ CD4 T Cells in Periphery and Prevents Infiltration of T-bet+ IL-17, IFN-γ Producing T Cells into CNS
por: Sinha, Sushmita, et al.
Publicado: (2011) -
Surviving the storm: Dealing with COVID-19
por: Vandenbark, Arthur A., et al.
Publicado: (2020) -
Regulation of the mTOR-Rac1 axis in platelet function
por: Aslan, Joseph E., et al.
Publicado: (2012) -
A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury
por: Vandenbark, Arthur A., et al.
Publicado: (2019) -
Data detailing the platelet acetyl-lysine proteome
por: Aslan, Joseph E., et al.
Publicado: (2015)